Positron emission tomography is a unique noninvasive imaging technique that provides cross-sectional images of radiotracer concentrations in myocardium and permits measurement of blood flow as well as metabolism. Ammonia and giutamate have been labeled with the positron-emitter I3 N (half-life 10 minutes) for use with positron emission tomography as tracers of flow and metabolism, respectively. In order to characterize the fate of these 13 N-labelled compounds in myocardium, isolated rabbit interventricular septa were used to study the kinetics of [ P ositron emission tomography (PET) permits the noninvasive assessment of myocardial flow and metabolism in vivo using selected positron-emitting compounds.
Positron emission tomography is a unique noninvasive imaging technique that provides cross-sectional images of radiotracer concentrations in myocardium and permits measurement of blood flow as well as metabolism. Ammonia and giutamate have been labeled with the positron-emitter I3 N (half-life 10 minutes) for use with positron emission tomography as tracers of flow and metabolism, respectively. In order to characterize the fate of these 13 N-labelled compounds in myocardium, isolated rabbit interventricular septa were used to study the kinetics of [ P ositron emission tomography (PET) permits the noninvasive assessment of myocardial flow and metabolism in vivo using selected positron-emitting compounds. 12 The positron-emitter nitrogen-13 ( 13 N) can be used to label ammonia as well as various amino acids. The initial uptake and retention of 13 N-labelled ammonia ( I3 NH 3 ) has been shown to be dependent on flow and metabolism, resulting in the use of I3 NH 3 as a myocardial flow tracer. 3 " 7 Giutamate has been labelled with 13 N ([ l3 N]glu) and has also been used with PET to image the heart. 8 " 10 Canine studies with PET from our laboratory indicated that [ 13 N]glu uptake was increased relative to I3 NH 3 uptake during ischemia. 9 These findings suggested that [
13 N]glu uptake may be a useful marker of ischemia when flow is decreased.
Giutamate metabolism is important in the heart for multiple reasons. It plays a key role in linking nitrogen metabolism with the citric acid cycle." 12 The malate-using tracer quantities of [
13 N]glu that do not perturb the steady state kinetics of glutamate metabolism in the myocardium. This is an important distinction when compared to high mass levels required for isotopic studies with 15 N (measured by mass spectrometry or nuclear magnetic resonance).
Our ultimate goal is to characterize ischemia in vivo using metabolic tracers with PET. To accomplish this, it is necessary to investigate the kinetics of each metabolic tracer in a controlled environment, such as an isolated heart preparation as we have previously done. 6727 The purpose of the current study was specifically to characterize 13 NH 3 and [ l3 N]glu metabolism in isolated myocardium under anoxic conditions. Because anoxia results in increased glycolytic flux and increased pyruvate production, 28 -29 we hypothesized that one of the effects of anoxia on [ 13 N]glu metabolism would potentially be due to increased pyruvate production. Therefore, we studied the effects of the addition of 2 mM pyruvate to the perfusate on [ 
Materials and Methods

Experimental Model
The arterially perfused interventricular septum of nonfasted male New Zealand white rabbits (1.5-2.0 kg) was the experimental model used in this work.
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This model was chosen for the following reasons: it is ideally suited for on-line coincidence counting of positron emissions from tissue without interference from radioactivity in cardiac chambers (as in Langendorff preparations); flow can be delivered in the physiologic range; and the preparation is stable in terms of mechanical function, ATP and creatine-phosphate levels, and potassium losses for 4-6 hours. In addition, glutamate had been shown to improve mechanical recovery after anoxia in this preparation. 22 These advantages outweighed the disadvantage that the isolated rabbit septum is a low workload preparation.
The heart was rapidly removed from heparinized rabbits, which were anesthetized with intravenous pentobarbital sodium (180 mg). The septal artery was immediately cannulated, and constant perfusion without recirculation was begun at a flow of 1.5 ml/min to give a flow rate of 1-1.5 ml/g/min. The standard perfusate used in our experiments contained (in mM) NaCl 130, CaCl 2 1.5, KC1 5, MgCl 2 1, NaH 2 PO 4 0.435, NaHCO 3 9, dextrose 5.56, NH 4 HCO 3 0.05, and insulin 5 U/l. Nonradioactive glutamate was not included in the perfusate because it markedly reduced the uptake of [ 13 N]glu, and 13 N-radioactivity was difficult to measure in tissue and effluent. In previous unpublished experiments in rabbit, we have determined that in vivo there is a large gradient for glutamate between the tissue and vascular space with tissue concentrations 50-100 times higher than plasma concentrations. In the septal preparation, we have also demonstrated that between 1 and 3 hours of perfusion (the time during which the reported experiments took place), tissue concentrations of aspartate, alanine, glutamate, and glutamine were relatively stable.
The septum was isolated and suspended between 2 coincidence Nal (Tl) detectors aligned 180° apart. The vertical vector of developed and rest tension was measured with a strain gauge transducer. Temperature was maintained at 37 ±0.5° C by heating the perfusate, which was delivered without recirculation. The septa were paced at 72 beats/min. 30 The gaseous I3 NH 3 (175-200 mCi) was then bubbled into isotonic saline to be used for I3 NH 3 injections or dissolved in 3 ml of a solution (pH 7.4) containing 30 mM sodium phosphate, 0.5 mM a-ketoglutarate, and 0.1 mM NADH. The second solution was passed by gravity through an enzyme column on which bovine liver glutamate dehydrogenase had been immobilized. 3132 The column was then washed with 6 ml of 30 mM sodium phosphate buffer (pH 7.4), and the combined elutions were passed through a cation exchange resin that retained 13 NH 3 . The eluate was made isotonic and contained approximately 5-10 mCi/ml of [ l3 N]glu at the time of bolus injection into the septa.
Preparation
Experimental Protocols
TIME-ACTIVITY CURVES. Bolus injections (0.05 ml) of [ l3 N]glu were rapidly delivered intra-arterially to septa first under control conditions and then approximately 1.5 hours later during perfusion with either 2 mM pyruvate added to the perfusate (n = 5) or an anoxic (n = 6) perfusate. The 2 mM pyruvate was present in the perfusate for at least 30 minutes prior to the second injection of [ 13 N]glu. Anoxia (oxygen content <0.1 vol%) was introduced by perfusing with the standard solution equilibrated with 98% N 2 /2% CO 2 beginning 10 minutes prior to the second bolus injection, which was also nonoxygenated. In 4 additional septa, I3 NH 3 was injected first under control conditions and then during anoxia using the same protocol.
Coincidence counting (time-window = 10 nanoseconds) of 13 N radioactivity from the septa was recorded for 30 minutes after each bolus and stored on line in 0.1-second increments on a digital computer (Scintigraphic Data Analyzer 5407, Hewlett Packard). The coincidence counting system used for these experiments included 2 Nal (Tl) scintillation detectors (1.5 inches by 3.0 inches) aligned 180° apart with relatively fast photomultipliers (RCA 4855, which have a 2-nanosecond rise time). The anode signal from the photomultipliers was directed into a fast ( x 10) preamplifier (Ortec 9301) and from there to a fast constant fraction discriminator (> 100 MHz) (Ortec 934) using the dual high/low threshold technique. The timing output pulse for the above discriminator was set at 6 nanoseconds to give an overlap coincidence timing of 10 nanoseconds with a LeCroy 365AL Regenerative Majority Coincidence Module. The mass of the rabbit septum was small (approximately 1 g), and the detectors were well shielded; therefore, there was little scatter. Typically the coincidence counts were 10-15% of the singles' counts, which is a relatively large fraction compared to the 1% commonly found with PET. The primary source of dead-time in the counting system was due to the decay time of the Nal (Tl) detectors' scintillation light, and the dead-time for the counting system as a whole was measured to be 10 /u,sec/coincident count. Peak coincidence counts for 13 NH 3 experiments were between 4,000-10,000 counts/sec and for [ l3 N]glu experiments were in the 2,000-4,000 counts/ sec range. At peak coincidence count rates of 2,000-10,000 counts/sec, the percentage dead-time losses were only 2-10%. Paralyzing dead-time losses were not observed. The random counts varied from 1% to a maximum of 2% of the total count rate in the count range we obtained. The time-activity curves were corrected for radioactive decay. The Marquardt-Levenberg algorithm 33 was used to fit each curve with a weighted sum of exponential components by a nonlinear regression program. The [ l3 N]glu curves were variably fit best by 2 or 3 exponential components as illustrated in Figure 1 . All 13 NH 3 curves fit best with 3 exponential components. The extraction fraction (EF) of each component was calculated by dividing the weighted coefficient of each component by the sum of the weighted coefficients as has been previously described. 67 The clearance halftime (t.J was calculated by dividing the natural logarithm of 2 by the rate constant from each component of the fitted curve. The nomenclature 1 and 3 denote the components with the shortest and longest t 1/5 's respectively.
CHEMICAL ANALYSES OF TISSUE AND EFFLUENT. An initial bolus (1.0 ml) of [ l3 N]glu, present in tracer quantities, was injected intra-arterially under control conditions, and a second bolus was injected intra-arterially 1.5 hours later during anoxia or perfusion with 2 mM pyruvate. A similar protocol was followed for injecting I3 NH 3 under control conditions and during anoxia. These larger volume injections were needed to have sufficient radioactivity for well-counting of tissue and effluent samples after chemical analysis because of the 10-minute half-life of I3 N. The boluses were oxygenated, or bubbled with 98% N 2 /2% CO 2 for the anoxia experiments, and then injected on-line over approximately 10-15 seconds while monitoring arterial pressure to ensure that arterial pressure did not exceed 90 mm Hg. At the completion of each injection, perfusate flow was resumed without recirculation at 1.5 ml/min. Samples of effluent (1.5 ml) were collected for chemical analyses between 5-6 minutes after each bolus was injected, and tissue samples (0.1 g) were obtained 6 minutes after each bolus. Simultaneous chromatographic analysis of tissue and effluent samples was not possible after a single bolus of [ The tissue samples were immediately placed into liquid nitrogen after removal and prepared for homogenization as previously described. 7 The tissue was added to 0.46 M perchloric acid (1.0 ml) prior to homogenization. The acid insoluble precipitate was separated from the supernatant, and the 13 N-radioactivity was counted using a Nal (Tl) well-counter. Five percent or less of the total 13 N-radioactivity was present in the protein precipitate. An aliquot of the neutralized supernatant was also counted. The remainder of the supernatant was placed on a cation-exchange resin, which retained 13 NH 3 . Column eluate was analyzed by reversed-phase, high-pressure liquid chromatography (HPLC) using o-phthaldialdehyde (OPT) precolumn fluorescence derivatization 31 to determine the amino acid concentrations. The concentrations of the nonradioactive amino acids are reported in /imoles/g tissue ( x 10 3 ). Effluent samples were collected in 0.46 M perchloric acid and analyzed as above with the omission of the homogenization step.
Statistical analysis was performed using paired t Time (minutes) *A11 6 controls best fit to 3 components; t2 component fits used for 3 anoxia runs that could not be fit to 3 components; Xn = 3; §all runs best fit to 2 components.
Values are means ± SD; EF, extraction fraction; t i^, clearance half-time in minutes; NS, no significant difference; p, level of significance.
tests. 34 Results are reported as means ± standard deviation.
Results
Control [ J 3N]glu (Preanoxia)
Time-activity curves obtained under control conditions after a bolus of [ l3 N]glu in 6 septa prior to anoxia were all best fit to 3 exponential components as illustrated in Figure 1 A. The 2 fastest components, denoted as 1 and 2, each had average clearance half-times (t 1/5 's) of 1.2 minutes or less (Table 1A) . Thus, by 5 minutes after a bolus of [ l3 N]glu (or 4-5 clearance t^'s), these 2 components were reduced to insignificant levels. The average half-time of the third component was 416 ± 201 minutes. The extraction fractions of these 3 components are listed in Table 1A . The third component, which represents the longest retention of I3 Nlabel in myocardium, had an extraction fraction of 0.35 ± 0 . 0 6 .
Chemical analyses to determine the distribution of 13 N-radioactivity was performed on tissue sampled 6 minutes after a bolus of [ 13 N]glu was given. Six minutes was chosen because it permitted clearance of the first 2 components and, therefore, permitted examination of the l3 N-radioactivity in the retained component; it was also short enough to have adequate counts for well-counting after chemical analysis. A representative example of the chromatographic results from a control experiment is illustrated in the top panel of Figure 2 . The tissue analyses from 3 septa revealed that the majority (70%) of the l3 N-label was present in [ l3 N-labelled glutamine ([ 13 N]gln) accounted for 5% of the l3 N-radioactivity and provided evidence for the presence of glutamine synthetase activity (E.C.6.3.1.2). The disr tribution of the l3 N-label in the effluent collected during the 1-minute interval between 5 and 6 minutes was very similar to the tissue distribution under control conditions (Table 2A) . Thus, under control conditions, l3 N-labelled amino acids are cleared from the myocardium in proportion to their tissue concentrations. The results for tissue and effluent distributions of l3 N-label listed in Table 2B for the control experiments that preceded the pyruvate studies were very Values are percent ± SD. ASP, aspartate; GLU, glutamate; GLN, glutamine; ALA, alanine; UC, unidentified compounds;p, significance level using paired / test. similar to those detailed in Table 2A but were derived from a separate set of 3 septa.
The relative specific activities for these control experiments (A and B) were calculated by dividing the percent distributions of 13 N-label in each amino acid by its measured concentration listed in Table 3 . the calculated specific activities are reported in Table 4 . In addition, the calculated specific activities were divided by the specific activity for glutamate to obtain normalized specific activities ( Table 4 ). The normalized tissue specific activities for aspartate and alanine from the 2 sets of control experiments ranged from 0.46-0.51 and 0.33-0.39, respectively, compared with 1.0 for glutamate. The glutamine tissue specific activities were 0.02.
Effluent specific activities are also listed in Table 4 (A and B) for the control experiments. Even though the distribution of 13 N-radioactivity in the amino acids was remarkably similar for tissue and effluent, the specific activity for effluent alanine was 4-9% of the specific activity for effluent glutamate, whereas the specific activity for tissue alanine was 33-39% of the specific activity of tissue glutamate. This occurred because the concentration ratio of alanine to glutamate in the effluent was approximately 3-4:1, whereas the same ratio in tissue was approximately 0.5:1. (Concentrations are presented in Table 3 .) Thus, a large proportion of the alanine that effluxed from myocardium was apparently not from the compartment that contained [ (Table 1A) was not signifi- (Table 3) .
ASP, aspartate; GLU, glutamate; GLN, glutamine; ALA, alanine;/? values are for comparisons between relative specific activities; NS, not significant. Relative specific activities were divided by the relative specific activity of glutamate for each set of septa and each set of conditions to yield the normalized specific activities, which are listed in parentheses.
cantly (p>0.05) changed during anoxia as compared with the EF(3) during control conditions. The clearance rate of this component was significantly (p < 0.05) faster during anoxia than under control conditions, but the standard deviation was large. The large standard deviation was in part related to the fact that the half-time for component 3 was long compared to the 30-minute data collection time used for generation of time-activity curves. Time-activity curves from a single septum after a bolus of [ (Table 2A and 
FIGURE 3. Normalized time-activity curves from a septum after injection of[ I3 N]glu under control conditions (XXX) and during anoxia (...). EF(3)s and t t/i (3)sfor each curve are denoted. Anoxia did not significantly change EF(3) but accelerated
There was a significant increase in [ Table 3A . These concomitant changes resulted in no significant increase in the tissue specific activity of alanine, as shown in Table 4A . Glutamate and aspartate tissue concentrations decreased 59% and 44%, respectively, but these changes were not significant at the p< 0.05 level (Table 3A) .
Effluent studies in 3 additional septa did not reveal an increase in the (Table 2A ). In addition, the concentration ratio of alanine to glutamate in the effluent during anoxia did not increase from control conditions despite the striking increase in the tissue ratio (Table 3A) . Moreover, the concentration ratio of effluent to tissue glutamate remained essentially unchanged from control to anoxia, whereas that of alanine fell substantially. Thus, the increased radioactive and nonradioactive alanine produced in tissue as a result of anoxia may be in a compartment(s) that is not cleared of alanine as rapidly as alanine is cleared from the tissue under control conditions.
Pyruvate [ 13 N]glu
The addition of 2 mM pyruvate to the perfusate in 5 septa did not change the extraction fractions derived from time-activity curves obtained after a bolus of [ (Table IB and Figure 4 ). The t w of the slow component was, however, significantly (p<0.05) faster with pyruvate present (Table IB) .
Two millimolar pyruvate resulted in a 218% increase in tissue 
FIGURE 4. Normalized time-activity curves from a septum after injection of [ l3 N]glu under control conditions (XXX) and during perfusion with 2 mM pyruvate (...). EF(3)s and ti A (3)s for each curve are denoted. Pyruvate did not significantly change EF(3) but accelerated i
with anoxia. Correspondingly, nonradioactive tissue alanine increased by 103%, and glutamate decreased by 58% (Table 3B ). The normalized specific activities for tissue revealed that there were no significant changes in the specific activity of alanine relative to that for glutamate (Table 4B ). The relative amount of l3 N-label in [ (Table 2B) as well as an increased concentration ratio of alanine to glutamate when compared with controls (Table 3B) . However, the concentration ratio of effluent to tissue glutamate remained stable, whereas the same ratio for alanine fell, as noted with anoxia. The normalized specific activities of glutamate and alanine did not change (Table 4B) .
Anoxia
I3 NH 3
Time-activity curves from a representative septum after bolus injections of 13 NH 3 during control conditions and during anoxia are presented in Figure 6 . A summary of the analyses of I3 NH 3 time-activity curves from 4 septa during control and anoxia appears in 13 N]glu is a substrate for both alanine aminotransferase and aspartate aminotransferase. These 2 enzymes are located in both the cytoplasm and mitochondria, 35 but the enzyme activity of alanine aminotransferase is significantly lower than that of aspartate aminotransferase in heart muscle. 3536 The alanine aminotransferase and aspartate aminotransferase reactions are near-equilibrium reactions and are freely reversible. 12 Therefore, if all the substrates have equal access to the enzymes and tracer steady state has been achieved, the specific activities for glutamate, alanine, and aspartate should be equivalent. We observed that the specific activities of the individual amino acids were constant under control conditions between 6 minutes and 15 minutes after a [ 13 N]glu bolus. 37 This suggested that tracer steady state had been achieved. Therefore, our finding that glutamate specific activities were always greater than those for alanine and aspartate suggested that l3 N]glu appears to enter a compartment in which the aminotransferases are more active than glutamine synthetase. This further confirms compartmentalization of glutamate in myocardium.
[ l3 N]glu time-activity curves were described by 2 or 3 components (Figure 1) . It was not clear from our studies why some control curves were best fit with 2 as opposed to 3 components. These mathematical components do not necessarily correspond to clearly defined physiological compartments. Based on the average intravascular luminal space of the septum, which is 10.5 ± 0 . 8 vol%, 39 and the flow rate of 1.5 ml/min, the estimated clearance half-time for the vascular space would be approximately 0.08 minute. This is clearly much shorter than the clearance half-time for the fastest glutamate component, which had a half-time of 0.20-0.27 minute. Therefore, component 1 does not correspond to the vascular space. Calculated theoretical half-times for clearance of free water from the septum are between 0.3-0.6 minute for a flow rate of 1.5 ml/min. 6 This suggests that component 1 may represent a freely diffusible glutamate compartment that has a smaller volume of distribution than water; however, there is no direct proof for this consideration. Component 2 is less likely to correspond to a clearly defined physiological compartment because it was not consistently present. Components 1 and 2 both had clearance half-times (t^'s) of approximately 1 minute or less; therefore, these components were essentially cleared from the tissue by 5 minutes after a bolus, leaving only the third component, with its relatively long clearance half-time, which permits myocardial imaging with positron emission tomography. Table 3 revealed that the efflux of alanine was greater than 3 times that of the other 3 amino acids. Specifically, the ratios of effluent to tissue concentration for anoxia control data (Table 3A) were ( x 10"
3 ) 5.3, 3.2, 5.3, and 21.6 for aspartate, glutamate, glutamine, and alanine, respectively, and corresponding values of 3.4, 1.4, 2.8, and 11.9 were determined for the control data from the pyruvate experiments (Table 3B ). Morgan et al 40 also found a preferential efflux of alanine from rat hearts out of proportion to its tissue concentration. A net alanine release from myocardium in normal humans using the coronary sinus technique has also been reported. 2021 '" These data are consistent with the proposed role of alanine efflux as the major mechanism for the transport of amino groups from muscle to liver where gluconeogenesis can take place 4243 because heart muscle does not contain the enzymes necessary for gluconeogenesis."' 44 Therefore, alanine formation from pyruvate provides a nontoxic alternative for transport of amino groups from myocardium. 13 N]ala. Our data are consistent with the hypothesis that the lack of oxygen in the perfusate resulted in increased pyruvate production secondary to enhanced anaerobic glucose metabolism. The increased pyruvate production resulted in increased production and accumulation of radioactive and nonradioactive tissue alanine via alanine aminotransferase. This agrees with the studies by Gailis and Benmouyal 45 using perfused guinea pig hearts in which increased glycolytic flux and increased pyruvate concentrations resulted in increased alanine production. Similarly, Mudge et al 20 observed an increase in alanine release from normal human myocardium during pacing, which could also increase pyruvate production. Increased alanine production has also been noted in autolyzing 46 and anoxic rabbit myocardium 47 ' 48 as well as in hypoxic perfused rat hearts. 4950 In addition, patients with coronary artery disease release more alanine at rest than subjects without coronary artery disease. 2021 The amount of alanine released was related to the severity of the coronary artery stenoses. 21 Thus, increased alanine production may result whenever pyruvate production is increased beyond the metabolic capabilities of the tricarboxylic acid cycle, such as during exercise, pacing, anoxia, and ischemia.
In addition, a body of evidence is accumulating consistent with anoxia-induced increased succinate production with concomitant substrate-level phosphorylation in rabbit heart. 48 " The production of increased succinate begins with augmented conversion of aspartate to oxaloacetate via aspartate aminotransferase and of glutamate to a-ketoglutarate via alanine aminotransferase. 51 Pyruvate is the second substrate of the second reaction and alanine is the by-product. 3 ) during anoxia, despite no change in the corresponding glutamate ratio. This suggests that anoxia may have induced alanine production in a tissue compartment that is cleared of alanine slower than the tissue as a whole was cleared of alanine under control conditions. The l3 N-label distribution data (Table 2A) 13 N]ala. Alanine aminotransferase has been identified in mitochondria as well as in the cytoplasm of myocardium, although the activity in mitochondria is only 10% of the cytoplasmic activity. 36 This suggests at least 2 anatomical compartments for alanine production. Cytosolic as well as mitochondrial subcompartmentation of alanine production are also possibilities. Based on studies in rat heart, Peuhkurinen et al 52 have suggested that there are 2 functional cytosolic pools for pyruvate (see Figure 7) : cytosolic pyruvate pool (I), which communicates directly with the glycolytic pathway, and cytosolic pyruvate pool (II), which communicates with pyruvate pool (I) but also directly with both the extracellular and mitochondrial pyruvate pools. In their studies, tissue alanine was more closely related to the mitochondrial pyruvate pool than with pool (I N]ala will be found predominantly in a pool(s) that is cleared more slowly of alanine than the tissue as a whole, and the effluent specific activity of alanine would be even less than under control conditions, which agrees with our data. Our data reemphasize the presence of compartmentation of amino acids but, because of limitations in using the shortlived 13 N, do not provide the detailed in situ measurements of metabolite concentrations and absolute tracer specific activities that are needed to further clarify the compartmentation of pyruvate and alanine in myocardium.
Pyruvate [ l3 N]glu
Pyruvate was added to the perfusate to test the hypothesis that the changes in [ Thus, the changes that were observed in [ 13 N]glu metabolism during anoxia appear to be predominently related to anoxia-induced increased pyruvate production from increased anaerobic glycolysis. The data are consistent with exogenous pyruvate entering the same pool for alanine synthesis that pyruvate production induced by anoxia enters. This agrees with studies in rat heart in which extracellular pyruvate was directly in communication with the functional cytosolic pool of pyruvate that communicated with the intracellular pool of" alanine.
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Anoxia
I3 NH 3 Anoxia resulted in a significant decrease in the EF(3) of I3 NH 3 without a change in clearance half-time or in the distribution of tissue I3 N. The decrease in EF(3) may be related to increased endogenous ammonia production and clearance from tissue to the vascular space. 18 It is also possible that the decrease in tissue glutamate (Table 3) we observed with anoxia was associated with a significant decrease in glutamate concentration specifically in the compartment containing glutamine synthetase. This could result in a significant diminution in 13 N-label retention. Finally, the activity of glutamine synthetase may have been reduced during anoxia because it is energy dependent and requires ATP.
Summary
In conclusion, the l3 N-label from [ N. In contrast, with I3 NH 3 , the mechanism of retention of the I3 Nlabel, which uses endogenous glutamate, was unchanged but the net extraction decreased. Although anoxia and ischemia do not have identical effects on myocardial lactate and pyruvate metabolism, the important differences in uptake and retention of the I3 Nlabel from 13 NH 3 (a flow tracer) and [ 13 N]glu (a metabolic tracer) during anoxia we observed encourage us to explore further the usefulness of PET with these tracers to diagnose ischemia in vivo. The degree and length of ischemia may well determine the exact pattern of uptake and retention that we will observe.
